Solventum Corp (SOLV) Stock
5 members of Congress disclosed 5 trades in SOLV since 2024: 1 purchase and 4 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 7 of the hedge funds AlphaScala tracks reported SOLV in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $92.58M.
Which members of Congress traded Solventum Corp (SOLV)?
Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start May 3, 2024.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| French Hill R-AR · House | 2025-12-31 | sale | $15k – $50k |
| Ron Wyden D-OR · Senate | 2025-02-06 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-01-15 | sale | $1k – $15k |
| Tommy Tuberville R-AL · Senate | 2024-05-03 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all SOLV political trades →Which hedge funds own SOLV?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 1.20M | $92.58M | +122% |
| D.E. Shaw David Shaw | 526K | $40.61M | +261% |
| Marshall Wace | 352K | $27.12M | NEW |
| Bridgewater Associates Ray Dalio | 178K | $13.73M | +5167% |
| Point72 Steve Cohen | 103K | $7.92M | NEW |
| Citadel Ken Griffin | 98K | $7.58M | -84% |
| Blackstone | 3K | $260.1K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →SOLV price chart
Powered by TradingViewWhat does Solventum Corp do?
Solventum Corporation is a leading American healthcare company that emerged as an independent entity following its spin-off from 3M in April 2024. Built on over 70 years of healthcare innovation, Solventum develops, manufactures, and commercializes solutions aimed at addressing critical needs in the global medical community. The company's operations encompass four primary segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum's products and services support a diverse array of healthcare applications, from advanced medical and surgical equipment to digital dental solutions and health information systems, impacting both providers and patients. With a workforce exceeding 20,000 professionals and a presence in 38 countries, Solventum operates more than 300 offices and facilities worldwide. The corporation has established itself as a significant force in the global healthcare sector, consistently advancing new technologies and fostering partnerships to improve health outcomes. Solventum emphasizes sustainability, innovation, and addressing healthcare disparities, aiming to create a healthier future. Its substantial scale and diversified healthcare portfolio position it as a critical player in shaping industry standards and supporting the delivery of effective, safer patient care across international markets.